Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Structure-Dependent Maternal-Fetal Transfer and Fetal Hepatic Accumulation of PFOA and Hexafluoropropylene Oxide (HFPO)-Based Alternatives: Implications for Fetal Liver Metabolic Disruption.

Created on 17 Nov 2026

Authors

Mengqi Zhang, Yawen Tian, Yitao Pan, Zhiwen Cheng, Jiayin Dai, Nan Sheng

Published in

Environmental science & technology. Volume 60. Issue 45. Pages 32411-32425. Nov 17, 2026.

Abstract

Hexafluoropropylene oxide (HFPO)-based compounds have been increasingly adopted as replacements for legacy per- and polyfluoroalkyl substances (PFAS) such as perfluorooctanoic acid (PFOA), yet evidence on developmental toxicity remains limited. This study investigated structure-dependent maternal-fetal transfer, fetal tissue distribution, and hepatic effects of PFOA and four HFPO-based alternatives, including hexafluoropropylene oxide dimer acid (HFPO-DA) and hexafluoropropylene oxide trimer acid (HFPO-TA) homologues, in gestational mice. All compounds were detected in maternal serum, fetal tissues, and amniotic fluid in a dose-dependent manner, but transplacental transfer efficiencies varied markedly. C9 HFPO-TA showed the greatest fetal accumulation, indicating enhanced fetal retention. Desorption electrospray ionization mass spectrometry imaging revealed preferential hepatic localization of PFOA and HFPO trimers, with fetal hepatic burden increasing with van der Waals volume, suggesting structure-dependent enrichment. Metabolomics showed broad alterations of fetal hepatic metabolism, dominated by altered lipids and lipid-like molecules. 5-Aminolevulinic acid, a key heme precursor, was consistently reduced, whereas ALAS1 and ALAD protein levels increased, indicating perturbation of heme biosynthesis. The provisional, study-specific developmental reference doses derived from fetal or placental endpoints were comparable to or lower than those based on maternal hepatomegaly, suggesting greater developmental sensitivity. These findings reveal structure-dependent fetal liver accumulation and support incorporating fetal-specific endpoints into PFAS risk assessment.

PMID:
43043284
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement